Joseph Smith is previously an Executive VP BD and General Counsel of Cepheid (now Danaher), Sr. VP BD at Applied Biosystems (ABI), VP Intellectual Property at ABI and PE Biosystems (Perkin-Elmer). Responsible for building and designing ABI's IP acquisition strategy, expanding its IP estate in fields such as PCR thermal cyclers, PCR reagents and DNA sequencing.
Current role